Canada Markets open in 4 hrs 51 mins

Replimune Group, Inc. (REPL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
21.20+0.44 (+2.12%)
At close: 04:00PM EST
21.20 0.00 (0.00%)
After hours: 04:47PM EST
Full screen
Loading interactive chart...
  • GlobeNewswire

    Replimune Provides 2021 Year End Review and Overview of Expected 2022 Milestones

    CERPASS clinical trial with RP1 in CSCC on track to complete enrollment mid-year with the primary analysis trigger six months thereafter IGNYTE anti-PD1 failed melanoma, evaluating RP1 in combination with Opdivo® on track to release interim data in late 2022 Phase 2 development plan for RP2/3 to be presented in the first quarter of 2022 Replimune to provide corporate update at the 40th Annual J.P. Morgan Healthcare Conference on January 10, 2022 WOBURN, Mass., Jan. 10, 2022 (GLOBE NEWSWIRE) -- R

  • GlobeNewswire

    Replimune to Present at the 40th Annual J.P. Morgan Healthcare Conference

    WOBURN, Mass., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (Nasdaq: REPL), a clinical stage biotechnology company pioneering the development of a novel class of tumor-directed oncolytic immunotherapies, today announced that Philip Astley-Sparke, Chief Executive Officer of Replimune, will present at the 40th Annual J.P. Morgan Healthcare Conference being held virtually on Monday, January 10, 2022 at 7:30 AM ET. A simultaneous webcast will be available in the Investors section of Repli

  • Simply Wall St.

    Is Replimune Group, Inc. (NASDAQ:REPL) Expensive For A Reason? A Look At Its Intrinsic Value

    How far off is Replimune Group, Inc. ( NASDAQ:REPL ) from its intrinsic value? Using the most recent financial data...